Literature DB >> 24560111

Hepatocellular carcinoma: diagnosis, management, and prognosis.

Andrew J Page1, David C Cosgrove2, Benjamin Philosophe1, Timothy M Pawlik3.   

Abstract

The successful management of hepatocellular carcinoma (HCC) requires a multidisciplinary approach, incorporating hepatologists, oncologists, surgical oncologists, transplant surgeons, and radiologists. With improvements in technology and better long-term outcomes data, management strategies for HCC have become more methodical and more successful. This article focuses on some of the most critical advances relating to carcinogenesis, surveillance, and management.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; Locoregional therapy; Sorafenib; Transarterial chemoembolization (TACE); Transplantation

Mesh：

Year:  2013        PMID： 24560111     DOI： 10.1016/j.soc.2013.10.006

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  25 in total

1.  Frailty as a Risk Predictor of Morbidity and Mortality Following Liver Surgery.

Authors:  Faiz Gani; Marcelo Cerullo; Neda Amini; Stefan Buettner; Georgios A Margonis; Kazunari Sasaki; Yuhree Kim; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-03-06       Impact factor: 3.452

2.  Detection and screening of small molecule agents for overcoming Sorafenib resistance of hepatocellular carcinoma: a bioinformatics study.

Authors:  Jinli Lv; Bo Zhu; Liang Zhang; Qichao Xie; Wenlei Zhuo
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States.

Authors:  Li Xu; Yuhree Kim; Gaya Spolverato; Faiz Gani; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2016-02       Impact factor: 7.293

4.  [National S3 guidelines on hepatocellular carcinoma].

Authors:  C M Sommer; U Stampfl; H U Kauczor; P L Pereira
Journal:  Radiologe       Date:  2014-07       Impact factor: 0.635

5.  Up regulation of NAT10 promotes metastasis of hepatocellular carcinoma cells through epithelial-to-mesenchymal transition.

Authors:  Rui Ma; Jiang Chen; Shaojie Jiang; Shuang Lin; Xiuming Zhang; Xiao Liang
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

Review 6.  Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.

Authors:  Jia-Yan Ni; Lin-Feng Xu; Wei-Dong Wang; Hong-Liang Sun; Yao-Ting Chen
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

7.  Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in the treatment of advanced hepatocelluar carcinoma.

Authors:  Wei Li; Yaomei Wang; Daniel B Kellner; Lingdi Zhao; Linping Xu; Quanli Gao
Journal:  Oncol Lett       Date:  2016-05-25       Impact factor: 2.967

8.  A randomized controlled trial on patients with or without adjuvant autologous cytokine-induced killer cells after curative resection for hepatocellular carcinoma.

Authors:  Li Xu; Jun Wang; Yuhree Kim; Ze-Yu Shuang; Yao-Jun Zhang; Xiang-Ming Lao; Yong-Qiang Li; Min-Shan Chen; Timothy M Pawlik; Jian-Chuan Xia; Sheng-Ping Li; Wan-Yee Lau
Journal:  Oncoimmunology       Date:  2015-10-12       Impact factor: 8.110

Review 9.  Current Approaches in the Management of Hepatic Adenomas.

Authors:  Diamantis I Tsilimigras; Amir A Rahnemai-Azar; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Demetrios Moris; Eleftherios Spartalis; Jordan M Cloyd; Sharon M Weber; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-08-14       Impact factor: 3.452

10.  PubMed-supported clinical term weighting approach for improving inter-patient similarity measure in diagnosis prediction.

Authors:  Lawrence Wc Chan; Ying Liu; Tao Chan; Helen Kw Law; S C Cesar Wong; Andy Ph Yeung; K F Lo; S W Yeung; K Y Kwok; William Yl Chan; Thomas Yh Lau; Chi-Ren Shyu
Journal:  BMC Med Inform Decis Mak       Date:  2015-06-02       Impact factor: 2.796
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.